Onderzoeker
Aster Vandierendonck
- Trefwoorden:Hepatocellulair carcinoom
- Disciplines:Hepatologie, Kankerbiologie
Affiliaties
- Vakgroep Inwendige ziekten en Pediatrie (Departement)
Lid
Vanaf1 okt 2018 → 25 sep 2022 - Vakgroep Inwendige ziekten (Departement)
Lid
Vanaf1 okt 2016 → 30 sep 2018
Projecten
1 - 1 of 1
- Preklinische evaluatie van het therapeutisch potentieel van het moduleren van de ongevouwen eiwitrespons en deubiquitinase activiteit in de kankerstamcellen in hepatocellulair carcinoom.Vanaf1 okt 2016 → 30 sep 2020Financiering: BOF - Nieuwe Onderzoeksinitiatieven
Publicaties
1 - 10 van 11
- NOX1 inhibition attenuates the development of a pro‐tumorigenic environment in experimental hepatocellular carcinoma(2021)
Auteurs: Aster Vandierendonck, Helena Degroote, Bart Vanderborght, Anja Geerts
- Myeloid-specific IRE1alpha deletion reduces tumour development in a diabetic, non-alcoholic steatohepatitis-induced hepatocellular carcinoma mouse model(2020)
Auteurs: Sanne Van Campenhout, Laurentijn Tilleman, Sander Lefere, Aster Vandierendonck, Sarah Raevens, Xavier Verhelst, Anja Geerts, Filip Van Nieuwerburgh, Hans Van Vlierberghe, Lindsey Devisscher
- Myeloid-specific IRE1 alpha deletion reduces tumour development in a non-alcoholic steatohepatitis-induced hepatocellular carcinoma mouse model(2019)Volume: 70
Auteurs: Sanne Van Campenhout, Sander Lefere, Aster Vandierendonck, Anja Geerts
Pagina's: e380 - e381 - Angiopoietin-2 promotes pathological angiogenesis and is a therapeutic target in murine nonalcoholic fatty liver disease(2019)
Auteurs: Sander Lefere, Frederique Van de Velde, Anne Hoorens, Sarah Raevens, Sanne Van Campenhout, Aster Vandierendonck, Sara Neyt, Bert Vandeghinste, Christian Vanhove, Charlotte Debbaut, et al.
Pagina's: 1087 - 1104 - Angiopoietin-2 promotes pathological angiogenesis and is a novel therapeutic target in non-alcoholic fatty liver disease(2018)Volume: 68
Auteurs: Sander Lefere, Frederique Van de Velde, Anne Hoorens, Sarah Raevens, Sanne Van Campenhout, Aster Vandierendonck, Sara Neyt, Bert Vandeghinste, Christian Vanhove, Charlotte Debbaut, et al.
Pagina's: 753A - 753A - The epigenetically regulated miR-494 associates with stem-cell phenotype and induces sorafenib resistance in hepatocellular carcinoma(2018)
Auteurs: Daniela Pollutri, Clarissa Patrizi, Sara Marinelli, Catia Giovannini, Elena Trombetta, Ferdinando A Giannone, Maurizio Baldassarre, Santina Quarta, Yves-Paul Vandewynckel, Aster Vandierendonck, et al.
- Angiopoietin-2 as therapeutic target for pathological angiogenesis and inflammation in non-alcoholic steatohepatitis(2018)Volume: 68
Auteurs: Sander Lefere, Frederique Van de Velde, Sarah Raevens, Sanne Van Campenhout, Aster Vandierendonck, S Neyt, Christian Vanhove, Anne Hoorens, Christophe Casteleyn, Bruno Lapauw, et al.
Pagina's: S329 - S329 - Angiopoietin-2 as therapeutic target for pathological angiogenesis and inflammation in non-alcoholic steatohepatitis(2018)Volume: 81
Auteurs: Sander Lefere, F Van de Velde, Sarah Raevens, Sanne Van Campenhout, Aster Vandierendonck, Sara Neyt, Christian Vanhove, Anne Hoorens, CHRISTINE CASTELEYN, Bruno Lapauw, et al.
Aantal pagina's: 1 - The unfolded protein response underlies microenvironmental stress-induced phenotype switching leading to stemness and chemoresistance in human hepatocellular carcinoma(2016)Volume: 64
Auteurs: Yves-Paul Vandewynckel, O Govaere, Aster Vandierendonck, Debby Laukens, Annelies Paridaens, Eliene Bogaerts, Sarah Raevens, Christophe Van Steenkiste, Louis Libbrecht, Christophe Ampe, et al.
Pagina's: S583 - S583 - Next-generation proteasome inhibitor oprozomib synergizes with modulators of the unfolded protein response to suppress hepatocellular carcinoma(2016)Volume: 64
Auteurs: Yves-Paul Vandewynckel, Céline Coucke, Debby Laukens, Annelies Paridaens, Eliene Bogaerts, Aster Vandierendonck, Sarah Raevens, Christophe Van Steenkiste, Louis Libbrecht, Anja Geerts
Pagina's: S583 - S583